Skip to content
Search

Latest Stories

NHS waiting list levels 'frightening', Pharmacists warn

NHS waiting list levels 'frightening', Pharmacists warn
Pharmacists are react to a new Nuffield Trust report that reveals significantly slower recovery times for major surgeries compared to other high-income countries post-Covid-19

Pharmacists across England are sounding alarm over NHS waiting list levels and have described as "frightening" in a response to a new report by the Nuffield Trust.

The new report highlights the slow recovery of waiting times for major surgeries in England compared to other high-income countries since the peak of the Covid-19 pandemic.


The Nuffield Trust's analysis indicates that waiting times for hip and knee replacements in England have increased more significantly and remained high into 2023, in stark contrast to countries like Spain and Finland.

Average waiting times for hip replacements in England surged from approximately 87 days before 2020 to 180 days during the pandemic, and have only reduced to around 128 days over the past three years—still nearly 50 per cent longer than pre-pandemic levels.

Knee replacements saw similar delays, with average waiting times rising from about 91 days to 209 days in 2020 and remaining around 142 days since then.

In comparison, other countries have managed to recover more swiftly. For instance, Spain and Finland saw little change in waiting times for hip replacements post-2020, while Norway and Sweden experienced increases but to a lesser degree than England.

The situation is similar for knee replacements, where several countries have returned to or improved on their pre-pandemic waiting times.

Interestingly, England has performed better in reducing waiting times for cataract surgeries.

These procedures, which typically do not require overnight stays or extensive rehabilitation, have seen waiting times improve quicker than in many other countries.

Sarah Reed, Senior Fellow at the Nuffield Trust, commented, "Health systems worldwide are still grappling with the aftermath of the Covid-19 pandemic.

"However, it's striking that England's recovery pace for major surgeries like hip and knee replacements has been much slower.

"For some minor procedures, we've improved more quickly than nearly everywhere else.

"This raises important questions for the new government on addressing the elective backlog and improving system-wide efficiency."

Paul Rees, Chief Executive of the National Pharmacy Association, reacted to the report's findings, emphasising the need for a fundamental rethink of NHS operations.

"The Nuffield Trust’s conclusions are frightening and point to the need for a fundamental rethink about how the NHS operates to cut waiting lists.

"At a time when GP waiting times and hospital waiting times are causing deep distress to patients we need to think radically about shifting resources to maximise the capacity of every part of the health system.
“That means maximising the work of pharmacies to take the pressure away from GPs and hospitals over the management of long-term conditions like hypertension and minor ailments, and moving treatment and monitoring to GP surgeries to hospitals can concentrate on clearing the backlogs for secondary care.

Rees advocated for increased funding and radical reform to achieve the best outcomes for patients and reduce waiting times across the health service.

More For You

Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
 New CPCF arrangements: Community pharmacy secures record £617m funding boost

This record investment is a vital first step to getting community pharmacies back on their feet and fit for the future, says health minister Stephen Kinnock.

Photo credit: gettyimages

New CPCF arrangements: Community pharmacy secures largest funding boost in NHS

Following a six-week consultation with Community Pharmacy England (CPE), the government has committed an additional £617 million over two years to support the sector- the largest uplift in funding across the whole of the NHS.

The Department of Health & Social Care (DHSC) today (31) announced the funding arrangements for the Community Pharmacy Contractual Framework (CPCF) for 2024/25 and 2025/26.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less